A
ANIP icon

AlphaQuest’s ANI Pharmaceuticals ANIP Stock Holding History

AlphaQuest’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,784
Closed -$2.11M – 133
2025
Q4 		$2.11M Buy
26,784
+25,211
+1,603% +$2.18M 0.12% 181
2025
Q3 		$144K Buy
1,573
+1,466
+1,370% +$120K 0.01% 1571
2025
Q2 		$6.98K Sell
107
-409
-79% -$26.6K ﹤0.01% 1873
2025
Q1 		$34.5K Hold
516
– – ﹤0.01% 1607
2024
Q4 		$28.5K Sell
516
-9,377
-95% -$538K ﹤0.01% 1389
2024
Q3 		$590K Buy
9,893
+5,789
+141% +$353K 0.05% 593
2024
Q2 		$261K Buy
+4,104
New +$266K 0.04% 674
2024
Q1 		– Sell
-2,725
Closed -$150K – 1645
2023
Q4 		$150K Buy
+2,725
New +$150K 0.03% 688

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AlphaQuest's ANIP Position: Q1 2026 in Review

AlphaQuest sold out of ANI Pharmaceuticals (ANIP) in Q1 2026, closing a stake of 26,784 shares — an estimated $2.11M sold.

AlphaQuest first reported a position in ANIP in Q4 2023 and held it in 8 quarters. The position peaked at $2.11M in Q4 2025. 281 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • AlphaQuest reported no remaining ANI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 26,784 ANI Pharmaceuticals shares in Q1 2026, an estimated $2.11M.
  • AlphaQuest first reported a position in ANI Pharmaceuticals in Q4 2023 and held it in 8 quarters.
  • AlphaQuest's ANI Pharmaceuticals position peaked at $2.11M in Q4 2025.
  • 281 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.